AbbVie Inc. (NYSE:ABBV)'s Chief Executive Officer Richard Gonzalez said, "AbbVie Inc is not considering a big merger or an acquisition." He added, "As far as the appetite for a big deal, I can tell you that is not something that we are contemplating." The statements came after allaying speculations of the AbbVie launching a bid for Bristol-Myers Squibb Company (NYSE:BMY).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
169.2 USD | +0.70% | +0.68% | +9.18% |
12/07 | AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis | MT |
12/07 | AbbVie Seeks U.S., Europe OK of Rinvoq in Giant Cell Arteritis | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.18% | 297B | |
+61.53% | 856B | |
+38.95% | 631B | |
-3.66% | 359B | |
+15.06% | 325B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.67% | 177B | |
+2.47% | 165B | |
+2.41% | 126B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Denies Bid For Bristol